Chris Johnstone

Discuss Canada’s talent attraction strategy as part of the expansion of the nation’s industrial and research capacity. Engagement on government’s Innovation Agenda Biomanufacturing and Life Sciences Strategy as it relates to Health and Bio Sciences sector. Johnson & Johnson (Canada) Inc. supports the development of a strong life science strategy and emerging policies that may impact the life sciences ecosystem in Canada, including the use and development of medical devices, digital health and robotics. Development of Health Emergency Readiness Canada agency, and its role in promoting development of life sciences sector in Canada Zero plastic waste by 2030 – Regarding potential legislative proposal regulating harmful single-use plastic items and implementing implementation of plastic waste management programs and impact on medical technologies. Treasury Board initiative to address international regulatory cooperation as well as their work on the Canada US, and Canada EU Regulatory Cooperation Councils Proposed national pharmacare. Specifically, government’s intention to introduce a national pharmacare program. Modernizations of the Food and Drugs Act, with respect to inspection, reporting and confidential business information. Local manufacturing of healthcare products – Regarding the development of policies and programs (including funding programs) to support the expansion of existing manufacturing facilities or the establishment of additional manufacturing capacity in Canada. Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drugs Act and Regulations, specifically with respect to approval, regulation and life cycle management of therapeutic products, including Agile Regulations. Health Canada and the Patented Medicine Prices Review Board (PMPRB) regulatory implementation and specifically, pharmaceutical pricing policy issues arising from the Patented Medicine Regulations. Food and Drugs Act: Delays in product approvals and changes to existing products. COVID-19: Regarding the development of policies and programs to address the COVID-19 pandemic and support the recovery of the Canadian economy, including as it relates to tackling health equity across marginalized communities in Canada and surgical backlogs. Communication to officials on labelling and product monographs. Chemical Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in therapeutic products. Canadian Drug Agency: Specifically, the creation of a new Canadian Drug Agency and transition work to support pharmacare-related initiatives. Canada’s partnerships on global health and global community impact with Johnson & Johnson relating to maternal and child health, First Nations, mental health and other areas. Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Canada-United States-Mexico Agreement (NAFTACUSMA) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies.

Development of Health Emergency Readiness Canada agency, and role in promoting development life sciences sector. Subsequent Entry Biologics (SEBs): the need for regulatory amendments to facilitate their approval. Research and Development (R&D): Input on Canada's clinical trial approval and implementations processes; Investing in Canada in R&D. Proposed national pharmacare: Specifically, government’s intention to introduce a national pharmacare program. Modernization of Food & Drug Act: support for proposed regulatory changes, modernization and international harmonizations with other regulatory bodies (European Medicines Agency/U.S. Food and Drug Administration). Input into the Patented Medicines Price Review Board evaluation of annual R&D investments by companies in Canada based on Scientific Research and Experimental Development (SR&ED) tax rules. Working with PMPRB and legislators to ensure appropriate measures of R&D investment are in place. Incentives and programs to attract and support manufacturing activities in Canada Health Canada and the Patented Medicine Prices Review Board(PMPRB) regulatory implementation and specifically, pharmaceutical pricing policy issues arising from the Patented Medicine Regulations. Health Canada's enforcement of Canada's Food and Drugs Act and Regulations as they relate to the cross border sale of drugs to the United States. COVID-19: Regarding the development of a COVID-19 vaccine & policies and related to the COVID-19 pandemic. Comprehensive Economic Trade Agreement with Europe (CETA) and pharmaceutical intellectual property protection. Communications regarding the maintenance of domestic supply of essential drug products. Canadian Drug Agency: Specifically, the mandate and creation of a new Canadian Drug Agency and transition work to support pharmacare-related initiatives. Canada-United States-Mexico Agreement (CUSMA) and pharmaceutical intellectual property protection. Canada's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement. An amendment to the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations") regarding the right to appeal.

Seek funding and support for the institution’s teaching, and research and development enterprise in life sciences, basic and applied sciences, social sciences, humanities and fine arts and mental health. Support for the implementation and operation of the Canada Water Agency Support for institutional compliance with federal research security requirements. Seek program development and support for Indigenous-led research Seeking program development for career opportunities for Indigenous post-secondary graduates Seeking greater efficiencies and continued funding of the Canada Student Loan Program Seek funding for international opportunities in student experience through academic exchanges, study abroad and international student visits to Canada Secure funding for Major Science Infrastructure Policy development and research funding for knowledge transfer and the commercialization of research Increase federal funding to the Canada Graduate Scholarship Program and other national initiatives in support of graduate students Funding for research and campus infrastructure Funding for internships, fellowships and student work-integrated learning Facilitation of improved policies that impact international students and other highly qualified personnel Discuss post-secondary institutions' role in securing Canada's water future through education and research. Discuss post-secondary institutions' role in securing Canada's energy future through research and teaching. Development of a national program for the provision of long-term operating funding for major science initiatives like the Canadian Light Source (CLS) and the Vaccine and Infectious Disease Organization (VIDO) Continue and increase funding to the Tri-Agency (CIHR, NSERC, SSHRC) in order to maintain an internationally competitive research and development infrastructure. Continue and increase funding to the Indirect Costs of Research Program in order to maintain an internationally competitive research and development infrastructure Continue and increase funding to the Canada Foundation for Innovation in order to maintain an internationally competitive research and development infrastructure. Budget bills in support of the federal role in post-secondary education, research and the science and technology framework

CYBER SECURITY - Encourage the government to invest in cybersecurity innovation, talent, and infrastructure; modernize research and development; accelerate commercialization in the space; support the secure digitalization of small-and-medium-sized enterprises (SMEs); and improve the global competitiveness of Canada’s cybersecurity industry. ARTIFICIAL INTELLIGENCE - Advocate for future-proofed, globally competitive, and interoperable policies that position artificial intelligence as a positive economic driver, and support the responsible development, deployment, and use of AI in business. PRIVACY AND ACCESS TO INFORMATION - Ensure that the modernization of Canada’s privacy legislation strikes the right balance between protecting consumers and promoting the ability of firms to innovate and compete by responsibly and securely using data. HOUSING - Support policies that enable the creation of more housing supply, incentivize investment in residential construction, and restore housing affordability for Canadian families. NATIONAL SECURITY/ECONOMIC SECURITY - Advancing policies related to enhancing Canada’s economic and national security. Key priorities include strengthening economic resilience, prudently navigating geopolitical challenges to trade and international relations, safeguarding business operations against new and emerging threats, and fostering conditions for economic growth. TRANSPORTATION - Regarding the consistent funding of trade-enabling infrastructure projects; the development of a competitive and efficient transportation network including all modes of transportation. TELECOMMUNICATIONS - Creating the right investment incentives to foster vibrant competition in the sector as a whole; responding to decisions regarding third-party access that will impact the deployment of internet services in rural and remote communities; and responding to regulatory proposals re: cell phone pricing. TAXATION AND FINANCE – With regard to undertaking a comprehensive and independent tax system review. TAXATION AND FINANCE – With regard to the measurement and improvement of Canada’s tax competitiveness, including: reforming the taxation, remittance, filing and audit processes of Canadian businesses; removing tax barriers for childcare expenses; addressing the taxation of family business transfers; and mobilizing private capital for recovery and growth. TAXATION AND FINANCE - With regard to modernizing our financial systems through open banking and digital currencies TAXATION AND FINANCE - Responding to proposals addressing taxation of digital services. TAXATION AND FINANCE - Maintaining and expanding real-time data made freely available to Canadian businesses, municipalities, academic researchers, and community groups. SMALL BUSINESS – Legislation, regulations and support programs that give Canadian small and medium-sized enterprises (SMEs) the tools to grow in Canada and internationally, including reducing their red tape and compliance burden. PRIVACY AND ACCESS TO INFORMATION - Improving digital privacy legislation to meet the needs of industry. PENSIONS - Treatment of corporate pensions in the event of bankruptcy. NATURAL RESOURCES - Support for the adoption of policy recommendations to strengthen Canada’s world-leading position in the mining industry, oil and gas, and forestry products. OPEN DATA - Maintaining and expanding real-time data made freely available to Canadian businesses, municipalities, academic researchers, and community groups. LABOUR: Ensuring that any changes to the Canada Labour Code are implemented in response to defined and demonstrated issues and not to increase regulatory burdens for employers. INTERNATIONAL TRADE – With respect to issues relating to import and export controls INTERNATIONAL TRADE - Negotiating bilateral, regional, and multilateral trade agreements and promoting them to Canadian businesses. INTERNATIONAL TRADE - Improving federal laws and regulations pertaining to responsible business conduct r

Communications regarding federal housing policies and government initiatives to support student housing development. Communications with various designated public office holders regarding health programming and investments to further health research and population health outcomes. Federal Research Granting Councils (NSERC, SSHRC, CIHR): 1) Communication with various designated public office holders to inquire on the status research funding programs; and 2) Communications to various designated public office holders to advocate for continued and increased granting council funding for the sector. Communications with various designated public office holders regarding jobs, creating skills development and work-integrated learning. Communications with various designated public office holders regarding investment in science and technology Communications with various designated public office holders regarding international education and to discuss policy changes to immigration that impact students and faculty. Communications with various designated public office holders regarding adaptation and mitigation of climate change, and other environmental policies. Communications with various designated public office holders for increased investment in sector infrastructure. Communications with various designated public office holders for increased funding to the Research Support Program of SSHRC, NSERC and CIHR.